FDA inspections of tissue banks remain a work in progress, and no clear path yet exists for procuring human tissues for biomedicine or drug development. Emily Waltz investigates.
References
Waltz, E. Nat. Med. 12, 487–488 (2006).
Human Tissue Task Force. 2007 Report (Department of Health & Human Services, Public Health Service, Food and Drug Administration, Bethesda, Maryland, USA, 2007). <http://www.fda.gov/cber/tissue/httf07report.htm>.
Waltz, E. Nat. Med. 13, 391 (2007).
National Institutes of Health Revitalization Act of 1993 <http://www.hhs.gov/ohrp/humansubjects/guidance/publiclaw103-43.htm>.
Anonymous. Taken without consent. The Guardian 31 January (2001) <http://society.guardian.co.uk/alderhey/comment/0,431159,00.html>.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waltz, E. Tracking down tissues. Nat Biotechnol 25, 1204–1206 (2007). https://doi.org/10.1038/nbt1107-1204
Issue Date:
DOI: https://doi.org/10.1038/nbt1107-1204
- Springer Nature America, Inc.
This article is cited by
-
Racial/Ethnic Differences in Comprehension of Biospecimen Collection: a Nationwide University of Rochester Cancer Center NCI Community Oncology Research Program Study
Journal of Cancer Education (2020)
-
Predictors of biospecimen donation in the Black Women’s Health Study
Cancer Causes & Control (2016)
-
Disparities in knowledge and willingness to donate research biospecimens: a mixed-methods study in an underserved urban community
Journal of Community Genetics (2014)